Anna Kalema
Associate Professor
Research Interests
Make your next move.
Prepare your application
Review drafts before you send them.
Explore related searches
Articles (11)
Year:
2026
Year:
2026
Year:
2025
Introduction Patients who survive admission to intensive care unit (ICU) for critical illness are at high risk of developing muscle atrophy and weakness, commonly diagnosed as ICU-acquired weakness (ICUAW). The development of ICUAW is closely linked to long-term symptoms and impairments known as post-intensive care syndrome (PICS). Despite heightened recognition of impairments, there is limited research supporting effective interventions to improve muscle and physical outcomes after hospital discharge. Prior to developing and testing interventions for ICU survivors, it is imperative to understand the trajectory of muscle and physical function recovery following an ICU stay. The purpose of this study is to longitudinally investigate skeletal muscle health and physical function outcomes after ICU admission. Methods and analysis This protocol describes a single site, prospective, observational study in adult patients who have survived a critical illness (ie, sepsis or acute respiratory failure). Patients will participate in a battery of testing including primary outcomes: muscle power and physical function; and secondary outcomes: muscle strength, muscle size, endurance and physical activity (by accelerometry) at hospital discharge and 3, 6, and 12 months post-discharge. A subset of patients will participate in muscle biopsy and venipuncture. To examine if the trajectory of recovery predicts primary outcomes, we will perform multivariate linear regression models in 150 evaluable patients. To examine differences in molecular and cellular outcomes in plasma and muscle tissue, a control group of community-dwelling adults without history of an ICU stay will be enrolled as a comparator group. Enrolment started on 18 October 2022 with an estimated completion date of 1 August 2027. Ethics and dissemination This protocol was approved by the University of Kentucky Office of Research Integrity Medical Internal Review Board (# 77407), with patients providing informed written consent. We anticipate our findings to establish recovery trajectories, improving the classification of patients who experience sustained physical disability. Improved identification of recovery trajectories of muscle and physical function enables future studies to employ an individually targeted rehabilitation approach, that is, precision medicine, with the goal of improving patient outcomes. The cellular findings will support the development of novel interventions specifically designed for detecting underlying mechanisms. We intend to disseminate findings to patients, healthcare professionals, the public and other relevant groups via conference presentations and manuscripts without publication restrictions. Trial registration number NCT05537298 .
Year:
2025
Year:
2025
RATIONALE. Limited data exists on physical activity levels in patients who survive the intensive care unit (ICU) as they recover and transition back into the community. Prior data demonstrate that survivors of ICU have low levels of physical activity in the first week returning home from hospital. It remains unknown how activity levels change over the first 6 months after discharge. The purpose of this study is to quantify daily step counts in ICU survivors across three time points for the first 6 months of recovery. METHODS: We conducted a 6-month prospective observational study of adult survivors of ICU. Patients diagnosed with acute hypoxic respiratory failure or sepsis (≥18 years) who were ambulatory prior to hospitalization were enrolled in the study within 30 days of discharge. Patients wore a Garmin Vivo-Fit for a minimum of 10 days to establish mean daily step counts at three time points: post hospital discharge, 3 months, and 6 months. Mean and standard deviations were calculated for step counts and paired t-tests determined significant differences (p=<0.05). Bonferroni corrections were used for multiple comparison of step counts at post-discharge, 3 and 6 months. RESULTS: Forty-three participants had a mean age of 55.9 ± 12.9 years and 40% female. Clinical metrics included an average hospital stay of 25.4 days (± 20.5 days), mechanical ventilation duration of 5.1 ± 7.2 days, and Body Mass Index of 28.5 ± 6.3. At hospital discharge, 77% returned home, while 16% went to acute rehabilitation hospitalization, and 7% went to long-term care facility. Step counts averaged 2,558 ± 2,044 steps at post-discharge, 3,860 ± 2741 at 3 months, and 3,551 ± 2,000 at 6 months after discharge, showing a significant increase from post-discharge to 3 months (p=0.009) but no significant change from 3 to 6 months (p=0.559; Figure 1). At 6 months, the mean step counts were below the typical range for healthy adults aged 55 years (4,000-18,000 steps) and fell short of the Centers for Disease Control guidelines of 30 minutes of moderate-intensity physical activity (8,000-11,000 steps) for free-living adults. CONCLUSIONS. The findings emphasize that survivors of critical illness may require dedicated follow up and encouragement up to six months following hospitalization to regain normal aged, related levels of physical activity.
Year:
2025
OBJECTIVES: Persistent skeletal muscle dysfunction in survivors of critical illness due to acute respiratory failure is common, but biological data elucidating underlying mechanisms are limited. The objective of this study was to elucidate the prevalence of skeletal muscle weakness and fatigue in survivors of critical illness due to COVID-19 and determine if cellular changes associate with persistent skeletal muscle dysfunction. DESIGN: A prospective observational study in two phases: 1) survivors of critical COVID-19 participating in physical outcome measures while attending an ICU Recovery Clinic at short-term follow-up and 2) a nested cohort of patients performed comprehensive muscle and physical function assessments with a muscle biopsy; data were compared with non-COVID controls. SETTING: ICU Recovery Clinic and clinical laboratory. PATIENTS/SUBJECTS: Survivors of critical COVID-19 and non-COVID controls. INTERVENTIONS: None. MEASUREMENTS AND MAIN RESULTS: One hundred twenty patients with a median of 56 years old (interquartile range [IQR], 42–65 yr old), 43% female, and 33% individuals of underrepresented race attended follow-up 44 ± 17 days after discharge. Patients had a median Acute Physiology and Chronic Health Evaluation-II score of 24.0 (IQR, 16–29) and 98 patients (82%) required mechanical ventilation with a median duration of 14 days (IQR, 9–21 d). At short-term follow-up significant physical dysfunction was observed with 93% of patients reporting generalized fatigue and performing mean 218 ± 151 meters on 6-minute walk test (45% ± 30% of predicted). Eleven patients from this group agreed to participate in long-term assessment and muscle biopsy occurring a mean 267 ± 98 days after discharge. Muscle tissue from COVID exhibited a greater abundance of M2-like macrophages and satellite cells and lower activity of mitochondrial complex II and complex IV compared with controls. CONCLUSIONS: Our findings suggest that aberrant repair and altered mitochondrial activity in skeletal muscle associates with long-term impairments in patients surviving an ICU admission for COVID-19.
Year:
2024
Objective To examine the relationship between physical rehabilitation parameters including an approach to quantifying dosage with hospital outcomes for patients with critical COVID-19. Design Retrospective practice analysis from March 5, 2020, to April 15, 2021. Setting Intensive care units (ICU) at four medical institutions. Patients n = 3780 adults with ICU admission and diagnosis of COVID-19. Interventions We measured the physical rehabilitation treatment delivered in ICU and patient outcomes: (1) mortality; (2) discharge disposition; and (3) physical function at hospital discharge measured by the Activity Measure-Post Acute Care (AM-PAC) “6-Clicks” (6–24, 24 = greater functional independence). Physical rehabilitation dosage was defined as the average mobility level scores in the first three sessions (a surrogate measure of intensity) multiplied by the rehabilitation frequency (PT + OT frequency in hospital). Measurements and main results The cohort was a mean 64 ± 16 years old, 41% female, mean BMI of 32 ± 9 kg/m 2 and 46% (n = 1739) required mechanical ventilation. For 2191 patients who received rehabilitation, the dosage and AM-PAC at discharge were moderately, positively associated (Spearman’s rho [r] = 0.484, p < 0.001). Multivariate linear regression (model adjusted R 2 = 0.68, p < 0.001) demonstrates mechanical ventilation (β = − 0.86, p = 0.001), average mobility score in first three sessions (β = 2.6, p < 0.001) and physical rehabilitation dosage (β = 0.22, p = 0.001) were predictive of AM-PAC scores at discharge when controlling for age, sex, BMI, and ICU LOS. Conclusions Greater physical rehabilitation exposure early in the ICU is associated with better physical function at hospital discharge.
Year:
2024
Year:
2023
Year:
2023
Year:
2023
Collaborators (12)
Ashley Montgomery-Yates
Senior Vice Chair/ Physician
University of Kentucky
Ahmed Ismaeel
Assistant Professor
Auburn University
Esther Dupont-Versteegden
University of Kentucky
Matthew Mart
Assistant Professor of Medicine
Vanderbilt University Medical Center
Yuan Wen
University of Kentucky
Panagiotis Koutakis
Associate Professor
University of Nebraska Medical Center
Christine Latham
Assistant Professor- Research Title Series
University of Kentucky
Stacey Slone
Statistician Principal
University of Kentucky
Jamie Sturgill
Assistant Professor
University of Kentucky
Kirby Mayer
Scientist
University of Kentucky
Kate Kosmac
Assistant Professor
Augusta University
Benjamin Miller
Program Chair
Oklahoma Medical Research Foundation
Make your next move.
Prepare your application
Review drafts before you send them.